Multiplex Testing for Evaluation of Breast Cancer Risk, Longitudinal Study

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02514499

Enrollment

350

Registered

2015-08-03

Start date

2014-07-31

Completion date

2018-10-31

Last updated

2019-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

BRCA1/2 Negative

Keywords

patients

Brief summary

The overall goal of the proposed research is to evaluate the uptake of testing and longitudinal risks and benefits of multiplex testing for cancer susceptibility in BRCA1/2 negative patients. This model will inform the selection of the outcomes and potential mediators and moderators of these outcomes, to inform the debate over utility, risks, and benefits of clinical incorporation of multiplex testing for breast cancer susceptibility.

Interventions

OTHERQuestionnaires

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SCREENING

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* 1\. Women and men (at least 18 YO) 2. English speaking AND 3. Negative for BRCA1 and BRCA2 mutations

Exclusion criteria

1\. Non English speaking patients

Design outcomes

Primary

Measure	Time frame
Completion of questionnaires	2 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026